This study found that the mRNA expression levels of Kv1.3 and KCa3.1 in the PBMCs of patients with CAD were significantly higher than those in the PBMCs of healthy controls and simvastatin treatment inhibited the expression of Kv1.3 but not KCa3.1. This evidence concerns the gene KCNA3 and coronary artery disorder.